BrainChip (BRN) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
11 May, 2026Opening remarks and agenda
Acknowledgement of traditional custodians and welcome to attendees, both in-person and virtual.
Introductions of board members, executives, and auditors; confirmation of quorum and meeting procedures.
Explanation of voting and Q&A processes for both in-person and online participants.
Reflected on the inspiration, creation, and future direction of Akida, emphasizing ongoing innovation and vision for edge AI.
Outlined the agenda to review historical AI evolution, product viability, and strategic positioning.
Board and executive committee updates
Presentations from the founder, CEO, and non-executive director highlighted the company's evolution, strategic vision, and leadership continuity.
Board composition and re-election of directors were addressed, with unanimous recommendations for key board members.
Strategic initiatives and plans
Expansion from technology provider to full system provider, focusing on silicon, modules, and reference designs.
Deliberate targeting of defense, aerospace, wearables, medical, and industrial sectors for commercial growth.
Launch of developer hub, Akida Cloud, and partnerships with global distributors to broaden market reach.
Announced expansion of product offerings, including AKD1500, Akida 2x/3x, AKD2500, and AKD3500, with supporting models, reference designs, and IP.
Emphasized the importance of complete hardware and software solutions, including the MetaTF development platform.
Latest events from BrainChip
- Revenue up 72% and net loss reduced, with strong capital raises and edge AI focus for 2025.BRN
H2 20246 Apr 2026 - Revenue up 374% to $1.89M, net loss narrows, AKD1500 enters production, capital base strengthened.BRN
H2 20256 Apr 2026 - Cash position strengthened and new partnerships drive momentum for neuromorphic AI products.BRN
Q4 202529 Jan 2026 - Cash balance rose to $13.9M as AKD1500 enters volume production, backed by new capital and partnerships.BRN
Q3 20251 Dec 2025 - A pivotal year with a new product roadmap, higher bookings targets, and focus on shareholder alignment.BRN
AGM 202520 Nov 2025 - $35M placement and $2M SPP to accelerate edge AI commercialization and product expansion.BRN
Investor Presentation10 Nov 2025 - Edge AI and neuromorphic solutions drive growth across defense, healthcare, and consumer markets.BRN
Investor Presentation19 Oct 2025 - Revenue soared 859% and net loss narrowed, with new funding and partnerships fueling growth.BRN
H1 202521 Aug 2025 - Customer receipts surged and cash burn improved, supporting ongoing growth and innovation.BRN
Q2 202529 Jul 2025